Last checked at 5 Feb 2021 11:54
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | AON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 04 February 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
433,926 | 0.19% | 2,392,194 | 1.05% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
604,593 | 0.26% | 30,257 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 23,000 | 0.01% | 23,000 | 0.01% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,061,519 | 0.46% | 2,445,451 | 1.07% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 205.6400 USD |
Purchase | 1 | 206.0500 USD |
Purchase | 2 | 207.0600 USD |
Purchase | 100 | 205.5600 USD |
Purchase | 170 | 206.3600 USD |
Purchase | 200 | 205.6650 USD |
Purchase | 254 | 207.9399 USD |
Purchase | 300 | 205.6076 USD |
Purchase | 475 | 206.6115 USD |
Purchase | 500 | 205.9640 USD |
Purchase | 1,196 | 205.9600 USD |
Purchase | 1,550 | 206.1341 USD |
Purchase | 2,900 | 207.6872 USD |
Purchase | 6,939 | 205.9817 USD |
Purchase | 9,559 | 206.5679 USD |
Purchase | 9,964 | 206.5714 USD |
Purchase | 11,348 | 208.1000 USD |
Purchase | 18,231 | 207.5695 USD |
Purchase | 32,188 | 207.0351 USD |
Sale | 1 | 206.0500 USD |
Sale | 2 | 207.0600 USD |
Sale | 2 | 205.9800 USD |
Sale | 100 | 204.9900 USD |
Sale | 171 | 207.7766 USD |
Sale | 200 | 206.7200 USD |
Sale | 235 | 207.7462 USD |
Sale | 254 | 207.9399 USD |
Sale | 400 | 205.7450 USD |
Sale | 674 | 207.9234 USD |
Sale | 800 | 207.1187 USD |
Sale | 896 | 205.9600 USD |
Sale | 1,100 | 206.8459 USD |
Sale | 1,348 | 206.4555 USD |
Sale | 1,720 | 207.6878 USD |
Sale | 2,100 | 207.9038 USD |
Sale | 4,592 | 207.0864 USD |
Sale | 4,622 | 206.7760 USD |
Sale | 5,412 | 206.3940 USD |
Sale | 7,344 | 206.5236 USD |
Sale | 11,284 | 207.8042 USD |
Sale | 11,348 | 208.1000 USD |
Sale | 41,273 | 206.7733 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 5 Feb 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price |
| date |
|
| to which the option |
|
|
|
|
| or derivative |
|
|
|
|
| relates |
|
|
|
Call Options | Purchased | 23,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -23,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210205005247/en/
Copyright Business Wire 2021